Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

Catalyst Pharmaceuticals, Inc. (CPRX)

We couldn't retrieve the full text for this release. Read it on the company's site.